We showed that high PSA levels (> 8 ng /mL) and tumour hypoxia (GLUT-1 > 19.1%) or lower nuclear hTERTLI (≤6.7%) and VEGFLI (≤11.0%) expression were negative prognostic factors for BRFS. The gene discussed is SLC2A1; the disease is neoplasm.